Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Biogen, Civitas, Rhythm, Alkermes, & More 08/29/14 Boston
NJ’s Medicine Chest Thins Again as GE Health Unit Heads for MA 08/19/14 Boston
Enumeral Raises $21.5M, Heads to the OTC Via Reverse Merger 08/04/14 Boston
East Coast Biotech Roundup: Acceleron, Seres, Sage, & More 07/18/14 Boston
New Jounce CEO Aims to Place the Right Immuno-Oncology Bets 07/11/14 Boston
Jounce Taps Merck Vet to Lead Cancer Drug Push 07/10/14 Boston
East Coast Biotech Roundup: Accelerate LI, ASCO, Akebia, & More 06/09/14 Boston
Merck Scoops Up Idenix in $3.85B Buyout 06/09/14 Boston
RNA Therapeutics Are Here to Stay 06/05/14 San Diego
East Coast Biotech Roundup: Bristol, PTC, Ophthotech, & More 05/27/14 Boston
East Coast Biotech Roundup: LTI, SolveBio, Proteon, & More 05/16/14 Boston
Celldex, Bristol-Myers Cut Deal on Immuno-Oncology Combo Trial 05/14/14 New York
Digital Health Check-Up: More Dollars, Fewer Bracelets 05/12/14 San Francisco
East Coast Biotech Roundup: Mergers, Rhythm, Regeneron, & More 05/09/14 Boston
West Coast Biotech Roundup: Alder IPO, Exelixis, Corcept, and More 05/09/14 San Diego
San Diego’s Ambrx Files for IPO to Advance Antibody-Drug Conjugates 05/05/14 San Diego
East Coast Biotech Roundup: Concert, Merrimack, Vertex, & More 05/02/14 Boston
How A Kidney Drug Almost Torpedoed Concert Pharma’s IPO 04/25/14 Boston
Just 7 Tickets Left for Our What’s Hot in Cancer Event April 22 04/21/14 Seattle
Syndax Plots $69M IPO For Cancer Drug’s Stretch Run 03/27/14 Boston
Genentech Joins “What’s Hot in Cancer Immunotherapy” Apr. 22 03/07/14 Seattle
East Coast Biotech Roundup: VentriNova, RainDance, Biogen, & More 03/07/14 Boston
Biogen, Eisai Join Up in Alzheimer’s Drug Pact 03/05/14 Boston
Merck Joins ‘What’s Hot in Cancer Immunotherapy’ Apr. 22 03/04/14 Seattle
East Coast Biotech Roundup: Sigal, Radius, SHIN-NY, & More 02/28/14 Boston
Elliott Sigal, Bristol’s Former R&D Chief, on Life After Big Pharma 02/25/14 New York
Join Xconomy for ‘What’s Hot in Cancer Immunotherapy’ on April 22 02/20/14 Seattle
Immuno-Oncology Fever Rages as Novartis Snaps Up CoStim 02/18/14 Boston
East Coast Biotech Roundup: Genocea, Eleven, NIH/Pharma, & More 02/07/14 Boston
Enanta, No Longer Obscure, Seeks Slice of Big Hepatitis C Market 01/24/14 Boston
Page 1 of 16 next page »